Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$82.78 - $101.0 $1.53 Million - $1.86 Million
-18,453 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$90.71 - $108.28 $967,784 - $1.16 Million
-10,669 Reduced 36.64%
18,453 $1.79 Million
Q4 2020

Feb 16, 2021

SELL
$92.08 - $124.48 $395,944 - $535,264
-4,300 Reduced 12.87%
29,122 $3.27 Million
Q3 2020

Nov 04, 2020

SELL
$66.45 - $92.7 $106,320 - $148,320
-1,600 Reduced 4.57%
33,422 $3.1 Million
Q2 2020

Jul 31, 2020

SELL
$57.09 - $79.27 $194,106 - $269,518
-3,400 Reduced 8.85%
35,022 $2.73 Million
Q1 2020

May 08, 2020

BUY
$48.11 - $82.22 $317,526 - $542,652
6,600 Added 20.74%
38,422 $2.25 Million
Q4 2019

Feb 11, 2020

SELL
$66.73 - $82.59 $320,304 - $396,432
-4,800 Reduced 13.11%
31,822 $2.55 Million
Q3 2019

Nov 01, 2019

BUY
$72.9 - $101.41 $160,380 - $223,102
2,200 Added 6.39%
36,622 $2.69 Million
Q2 2019

Aug 13, 2019

BUY
$73.54 - $97.8 $1.61 Million - $2.14 Million
21,869 Added 174.21%
34,422 $3.25 Million
Q1 2019

May 13, 2019

SELL
$48.7 - $86.6 $14,610 - $25,980
-300 Reduced 2.33%
12,553 $1 Million
Q4 2018

Feb 14, 2019

SELL
$45.57 - $74.26 $61,382 - $100,028
-1,347 Reduced 9.49%
12,853 $693,000
Q3 2018

Nov 14, 2018

SELL
$58.91 - $78.32 $5,891 - $7,831
-100 Reduced 0.7%
14,200 $1.11 Million
Q1 2018

May 03, 2018

BUY
$73.28 - $102.95 $1.05 Million - $1.47 Million
14,300 New
14,300 $1.31 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.